References in periodicals archive ?
In other countries (eg, South Africa), the generic Effexor XR came out even earlier and one generic company, Ciplo Medpro [9] , are already legally manufacturing and selling extended release venlafaxine capsules under the brand name Venlor XR in that country.
The goal in patenting extended release formulations has to be broad enough to prevent the development of generic alternatives, and narrow enough to prevent invalidity arguments.
If approved, the extended release formulation of lorcaserin is expected to be marketed as BELVIQ XR, which is the brand name conditionally approved by the US FDA, concluded the company.
Aceneuramic acid extended release is aimed to replace the deficient sialic acid substrate in patients with GNE Myopathy also called Hereditary Inclusion Body Myopathy.
We are pleased to have worked with Elite Pharmaceuticals to develop products which utilize the firm's extended release drug delivery technology.
is a specialty pharmaceutical company utilizing its innovative AcuForm[TM] drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs.
Reddya[euro](tm)s Laboratories Ltd unveils over-the-counter Fexofenadine HCl and Pseudoephedrine HCl extended release tablets(C)2011 M2 COMMUNICATIONS http://www.
M2 PHARMA-October 4, 2010-J&JPRD receives FDA Complete Response for tapentadol extended release NDA(C)2010 M2 COMMUNICATIONS
M2 EQUITYBITES-19 August 2010-Sun Pharma receives USFDA Approval for generic Venlafaxine extended release tablets(C)2010 M2 COMMUNICATIONS http://www.
M2 EQUITYBITES-22 July 2010-Caraco Pharmaceutical Laboratories Ltd unveils generic Wellbutrin SR extended release tablets in market(C)2010 M2 COMMUNICATIONS http://www.
King Pharmaceuticals and Depomed market Glumetza[TM] (metformin hydrochloride extended release tablets), a new once-daily extended-release metformin formulation that features AcuForm[TM] drug-delivery technology, for the treatment of adults with type 2 diabetes in the United States.
In addition, positive data from our Phase II clinical trial in DPN may offer us an opportunity to leverage our growing presence in the diabetes field, currently represented by our recently-launched Glumetza product, a novel, extended release formulation of metformin for the treatment of Type II diabetes.

Full browser ?